Crosne, France

Daniel Robin

This inventor holds 2 USPTO granted patents. Top assignees: Aventis Pharmaceuticals Inc., Rhone-Poulenc Rorer Pharmaceuticals Inc.. Active years: 2000-2002.


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2000-2002

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Exploring the Innovations of Inventor Daniel Robin

Introduction

Daniel Robin, based in Crosne, France, is a noteworthy inventor with a keen focus on developing innovative pharmaceutical compounds. With a track record of two patents, Robin has made significant contributions to the field of chiral chemistry, which plays a crucial role in drug development.

Latest Patents

Robin's latest patents include methods for the stereospecific preparation of chiral 1-aryl- and 1-heteroaryl-2-substituted ethyl-2-amines. These inventions are directed toward creating [(1-optionally substituted aryl)- or (1-optionally substituted heteroaryl)]-2-substituted ethyl-2-amines, characterized by their chirality at the 2-position. The patents also encompass the development of intermediates necessary for synthesizing these substituted ethyl-2-amines, showcasing Robin's expertise in chiral synthesis.

Career Highlights

Throughout his career, Daniel Robin has showcased his talent in pharmaceutical innovation while working for esteemed companies such as Rhône-Poulenc Rorer Pharmaceuticals Inc. and Aventis Pharmaceuticals Inc. His experience in these leading entities has garnered him insights into the pharmaceutical industry and has allowed him to enhance his inventive prowess.

Collaborations

Collaboration plays a vital role in the world of innovation, and Robin has worked alongside notable coworkers, including Luc Grondard and Jean-Paul Casimir. These collaborations have further enriched his experience and contributed to the successful development of his inventions.

Conclusion

Daniel Robin is a distinguished inventor whose work in the field of chiral chemistry presents valuable advancements in pharmaceutical development. His innovative patents demonstrate a commitment to enhancing drug formulation processes, positioning him as a significant figure in the landscape of contemporary inventors.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…